AAAAAA

   
Results: 1-20 |
Results: 20
HL60 CELLS EXHIBIT PARTICULAR ULTRASTRUCTURAL FEATURES DURING ALL-TRANS-RETINOIC ACID-INDUCED APOPTOSIS
Authors: BOBICHON H MAYER P CARPENTIER Y DESOIZE B
Citation: H. Bobichon et al., HL60 CELLS EXHIBIT PARTICULAR ULTRASTRUCTURAL FEATURES DURING ALL-TRANS-RETINOIC ACID-INDUCED APOPTOSIS, International journal of oncology, 12(3), 1998, pp. 649-653
THE EFFECT OF 12-ALKOXY MODIFICATION ON THE IN-VITRO ANTILEUKEMIC ACTIVITY OF N-METHYL 2,3,8,9-TETRAMETHOXYBENZO[C]PHENANTHRIDINIUM SALTS
Authors: MACKAY SP COMOE L DESOIZE B DUVAL O JARDILLIER JC WAIGH RD
Citation: Sp. Mackay et al., THE EFFECT OF 12-ALKOXY MODIFICATION ON THE IN-VITRO ANTILEUKEMIC ACTIVITY OF N-METHYL 2,3,8,9-TETRAMETHOXYBENZO[C]PHENANTHRIDINIUM SALTS, Anti-cancer drug design (Print), 13(7), 1998, pp. 797-813
MULTICELLULAR RESISTANCE - ANOTHER MECHANISM FOR MULTIDRUG-RESISTANCE
Authors: DESOIZE B GIMONET D JARDILLIER JC
Citation: B. Desoize et al., MULTICELLULAR RESISTANCE - ANOTHER MECHANISM FOR MULTIDRUG-RESISTANCE, Bulletin du cancer, 85(9), 1998, pp. 785-793
COFACTORS IN IN-VITRO INDUCTION OF APOPTOSIS IN HL60 CELLS BY ALL-TRANS-RETINOIC ACID (ATRA)
Authors: CARPENTIER Y MAYER P BOBICHON H DESOIZE B
Citation: Y. Carpentier et al., COFACTORS IN IN-VITRO INDUCTION OF APOPTOSIS IN HL60 CELLS BY ALL-TRANS-RETINOIC ACID (ATRA), Biochemical pharmacology, 55(2), 1998, pp. 177-184
EVALUATION OF A PREDICTION MODEL OF CISPLATIN DOSE BASED ON TOTAL PLATINUM PLASMA-CONCENTRATION
Authors: DESOIZE B BERTHIOT G MANOT L CONINX P DUMONT P
Citation: B. Desoize et al., EVALUATION OF A PREDICTION MODEL OF CISPLATIN DOSE BASED ON TOTAL PLATINUM PLASMA-CONCENTRATION, European journal of cancer, 32A(10), 1996, pp. 1734-1738
EVALUATION OF 2 DOSE INDIVIDUALIZATION METHODS FOR CARBOPLATIN
Authors: DESOIZE B DUFOUR R URIEN S KALTENBACH M COLIN P
Citation: B. Desoize et al., EVALUATION OF 2 DOSE INDIVIDUALIZATION METHODS FOR CARBOPLATIN, Anticancer research, 16(4A), 1996, pp. 2073-2078
ESTIMATION OF POTENTIAL DOUBLING TIME (TP OT) IN-VIVO, BY FLOW-CYTOMETRY - PRACTICAL PROBLEMS AND POSSIBLE SOLUTIONS
Authors: GORISSE MC DESOIZE B CARPENTIER Y NGUYEN TD
Citation: Mc. Gorisse et al., ESTIMATION OF POTENTIAL DOUBLING TIME (TP OT) IN-VIVO, BY FLOW-CYTOMETRY - PRACTICAL PROBLEMS AND POSSIBLE SOLUTIONS, Bulletin du cancer, 83(10), 1996, pp. 825-834
APOPTOSIS AND PROGRAMMED CELL-DEATH
Authors: DESOIZE B
Citation: B. Desoize, APOPTOSIS AND PROGRAMMED CELL-DEATH, Bulletin du cancer, 82(1), 1995, pp. 70-76
REVERSION OF RESISTANCE TO ADRIAMYCIN BY VANADATE ON 4 FRIEND-CELL SUBLINES
Authors: DESOIZE B BRIOIS F CARPENTIER Y
Citation: B. Desoize et al., REVERSION OF RESISTANCE TO ADRIAMYCIN BY VANADATE ON 4 FRIEND-CELL SUBLINES, International journal of oncology, 5(1), 1994, pp. 87-91
INDIVIDUAL DOSE ADAPTATION OF ANTICANCER DRUGS
Authors: DESOIZE B ROBERT J
Citation: B. Desoize et J. Robert, INDIVIDUAL DOSE ADAPTATION OF ANTICANCER DRUGS, European journal of cancer, 30A(6), 1994, pp. 844-851
COMPARISON OF 2 DOSE PREDICTION MODELS FOR CISPLATIN
Authors: DESOIZE B DUMONT P MANOT L URIEN S DUFOUR R BERTHIOT G
Citation: B. Desoize et al., COMPARISON OF 2 DOSE PREDICTION MODELS FOR CISPLATIN, Anticancer research, 14(6A), 1994, pp. 2285-2290
ANTICANCER DRUG-RESISTANCE AND INHIBITION OF APOPTOSIS
Authors: DESOIZE B
Citation: B. Desoize, ANTICANCER DRUG-RESISTANCE AND INHIBITION OF APOPTOSIS, Anticancer research, 14(6A), 1994, pp. 2291-2294
CULTURE CONDITIONS MODULATE THE EFFECTS OF ACLACINOMYCIN-A ON GROWTH,DIFFERENTIATION AND APOPTOSIS OF HL-60 CELLS
Authors: MAYER P CARPENTIER Y GORISSE MC DESOIZE B
Citation: P. Mayer et al., CULTURE CONDITIONS MODULATE THE EFFECTS OF ACLACINOMYCIN-A ON GROWTH,DIFFERENTIATION AND APOPTOSIS OF HL-60 CELLS, Anticancer research, 14(6A), 1994, pp. 2331-2337
CHARACTERISTICS OF 4 FRIEND-LEUKEMIA CELL SUBLINES RESISTANT TO ADRIAMYCIN
Authors: DESOIZE B BROGLIO C GORISSE MC BRIOIS F CARPENTIER Y DELVINCOURT C DUFER J
Citation: B. Desoize et al., CHARACTERISTICS OF 4 FRIEND-LEUKEMIA CELL SUBLINES RESISTANT TO ADRIAMYCIN, Anticancer research, 14(3A), 1994, pp. 995-1000
EFFECTS OF ACLARUBICINE ON GROWTH, DIFFER ENTIATION AND APOPTOSIS OF TUMOR-CELLS IN-VITRO
Authors: MAYER P GORISSE MC CARPENTIER Y DESOIZE B
Citation: P. Mayer et al., EFFECTS OF ACLARUBICINE ON GROWTH, DIFFER ENTIATION AND APOPTOSIS OF TUMOR-CELLS IN-VITRO, Bulletin du cancer, 81(8), 1994, pp. 670-676
CHRONOLOGY OF COMBINED CHEMOTHERAPY (5FU) AND RADIOTHERAPY .1. IN-VITRO STUDY
Authors: CARPENTIER Y DEMANGE L LOIRETTE M HIVET J DESOIZE B
Citation: Y. Carpentier et al., CHRONOLOGY OF COMBINED CHEMOTHERAPY (5FU) AND RADIOTHERAPY .1. IN-VITRO STUDY, Anticancer research, 13(6A), 1993, pp. 2177-2180
CHRONOLOGY OF COMBINED CHEMOTHERAPY (5FU) AND RADIOTHERAPY .2. IN-VIVO STUDY
Authors: DEMANGE L CARPENTIER Y LOIRETTE M HIVET J RIGAUD C DESOIZE B
Citation: L. Demange et al., CHRONOLOGY OF COMBINED CHEMOTHERAPY (5FU) AND RADIOTHERAPY .2. IN-VIVO STUDY, Anticancer research, 13(6A), 1993, pp. 2181-2186
TO WHICH CRITERION SHOULD THE DOSE OF ANTICANCER DRUG BE ADAPTED
Authors: DESOIZE B
Citation: B. Desoize, TO WHICH CRITERION SHOULD THE DOSE OF ANTICANCER DRUG BE ADAPTED, Bulletin du cancer, 80(5), 1993, pp. 376-390
THE ANTILEUKEMIC ALKALOID FAGARONINE IS AN INHIBITOR OF DNA TOPOISOMERASE-I AND TOPOISOMERASE-II
Authors: LARSEN AK GRONDARD L COUPRIE J DESOIZE B COMOE L JARDILLIER JC RIOU JF
Citation: Ak. Larsen et al., THE ANTILEUKEMIC ALKALOID FAGARONINE IS AN INHIBITOR OF DNA TOPOISOMERASE-I AND TOPOISOMERASE-II, Biochemical pharmacology, 46(8), 1993, pp. 1403-1412
CLINICAL PHARMACODYNAMIC-PHARMACOKINETIC RELATIONSHIPS OF CISPLATINUMAND ETOPOSIDE
Authors: DESOIZE B MARECHAL F CATTAN A
Citation: B. Desoize et al., CLINICAL PHARMACODYNAMIC-PHARMACOKINETIC RELATIONSHIPS OF CISPLATINUMAND ETOPOSIDE, Annales de biologie clinique, 51(2), 1993, pp. 125-128
Risultati: 1-20 |